下載本文檔
版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEGentiopicrosideCat. No.: HY-N0494CAS No.: 20831-76-9Synonyms: Gentiopicrin分式: CHO分量: 356.32作靶點: Cytochrome P450作通路: Metabolic Enzyme/Protease儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO :
2、150 mg/mL (420.97 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.8065 mL 14.0323 mL 28.0647 mL5 mM 0.5613 mL 2.8065 mL 5.6129 mL10 mM 0.2806 mL 1.4032 mL 2.8065 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Gentiopicroside種天然的環(huán)烯
3、醚萜苷,能夠抑制 P450 的活性,對 CYP2A6 的 IC50 和 Ki 值分別為 61 M和 22.8 M;Gentiopicroside 具有抗炎和抗氧化活性。IC50 & Target IC50: 61 M (CYP2A6) 1Ki: 22.8 M (CYP2A6) 11/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE體外研究 Gentiopicroside inhibits P450 activity, with an IC50 and a Ki of 61 M and 8.12 M for CYP2A6, also slightly
4、inhibits CYP2E1 activity with an IC50 of 1.6 mM, but shows no inhibition on CYP1A2 and CYP3A4 1.Gentiopicroside (12.5, 25 and 50M) inhibits RANKL-induced osteoclast formation from mouse bone marrowmacrophages (BMMs) in a dose-dependent manner, blocks the expression of osteoclast-related proteins,pre
5、vents receptor activator of nuclear factor-B ligand (RANKL)-triggered JNK and NF-B activation.Gentiopicroside (50M) also inhibits RANKL-induced bone resorption 3.體內(nèi)研究 Gentiopicroside (20, 40, and 80 mg/kg, p.o.) significantly reduces gastric ulcerindex in mice. Gentiopicroside(20, 40, and 80 mg/kg)
6、also ovbiously decreases the levels of HSP-70, TNF-, IL-6, MDA and increasesncreased GSH level and SOD activity. In addition, Gentiopicroside normalizes EGF and VEGF level in mice2.PROTOCOLCell Assay 3 Cell viability is evaluated using the CCK-8 assay. In brief, bone marrow macrophages (BMMs) (1104c
7、ells/well) are placed in a 96-well plate and cultured with various concentrations of Gentiopicroside (12.5, 25and 50 M) for 48 h in the presence of M-CSF (30 ng/mL) and RANKL (100 ng/mL). Then, 10 L of theCCK-8 solution is added to each well and the mixture is incubated for 4 h at 37C. The absorbanc
8、e isevaluated at 450 nm using a microplate reader 3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 2Administration 2 Mice are ran-domLy divided into six groups with 10 animals each. Drug is given by intragastric administrationonce a day for
9、 three consecutive days. Mice in the normal control group and the ethanol control group(negative control) receive saline at a dose of 2.5 mL/kg; Mice in the cimetidine control group (positive control)receive cimetidine at a dose of 100 mg/kg; mice in three Gentiopicroside investigative groups receiv
10、edifferent doses of Gentiopicroside (20, 40, and 80 mg/kg), respectively; On the third day, except that mice inthe normal control group receive saline, mice in other groups receive 70% ethanol at a dose of 0.01 mL/g byoral1 hr after the last intragastric administration. One hour after the induction,
11、 animals are euthanized underanesthesia by cervical dislocation, removed and cut the stomach longitudinally. The stomach are openedalong the greater curvature and rinsed slightly with ice-cold saline to remove the gastric contents, and thenthe severity of gastric mucosal injury is evaluated by gastr
12、ic ulcer index. Subsequently, eachanimalsstomach is cut into two moieties, with one moiety of stomach stored at 80C for biochemicalassessment and the other moiety immersed in 4% paraformaldehyde solution for histopathologicalexaminations 2.MCE has not independently confirmed the accuracy of these me
13、thods. They are for reference only.REFERENCES1. Deng Y, et al. In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6.Drug Metab Pharmacokinet. 2013;28(4):339-44. Epub 2013 Feb 19.2. Yang Y, et al. Protective effect of gentiopicroside fro
14、m Gentiana macrophylla Pall. in ethanol-induced gastric mucosal injury in mice.Phytother Res. 2018 Feb;32(2):259-266.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE3. Chen F, et al. Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-B and JNK signaling pathways. BiomedPharmacother. 2018 Apr;10
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 貴州城市職業(yè)學院《信息系統(tǒng)審計》2023-2024學年第一學期期末試卷
- 貴州財經(jīng)大學《工業(yè)機器人本體設計》2023-2024學年第一學期期末試卷
- 2025年上海市安全員C證考試題庫
- 2025云南省建筑安全員-B證(項目經(jīng)理)考試題庫
- 2025年上海市安全員知識題庫及答案
- 廣州珠江職業(yè)技術學院《汽車電子控制技術》2023-2024學年第一學期期末試卷
- 2025年河北建筑安全員《C證》考試題庫
- 2025廣東省安全員C證考試(專職安全員)題庫附答案
- 廣州應用科技學院《中國文化史》2023-2024學年第一學期期末試卷
- 廣州新華學院《光電成像原理與技術》2023-2024學年第一學期期末試卷
- 2025版工業(yè)制造工程墊資建設合同2篇
- ISO 56001-2024《創(chuàng)新管理體系-要求》專業(yè)解讀與應用實踐指導材料之4:4組織環(huán)境-4.2理解相關方的需求和期望(雷澤佳編制-2025B0)
- 2024年一級支行行長競聘演講稿例文(4篇)
- 健身房銷售人員培訓
- 菌種保存管理
- 廣東省廣州市2022-2023學年高二上學期期末考試化學試題
- 期末測試卷(試題)-2024-2025學年四年級上冊數(shù)學滬教版
- 中考必備高頻詞匯2600詞(單詞版)
- GB∕T 27552-2021 金屬材料焊縫破壞性試驗 焊接接頭顯微硬度試驗
- 外貿(mào)中常見付款方式的英文表達及簡要說明
- 抗壓偏壓混凝土柱承載力計算表格
評論
0/150
提交評論